Winter 08:Fall 11/28/07 4:19 PM Page 1 The Newsletter of amfAR, fThe Foundation for AIDS Research Winter 2008 Sharon Stone Named Global amfAR Appoints New Leadership Fundraising Chairman 2 Kevin Frost Named Chief Executive Officer POLICY REPORT mfAR has announced the appointment of Whither World Health? a Kevin Robert Frost as the Foundation’s new 3 chief executive officer. Frost was previously vice president for Global Initiatives at amfAR and has served as interim CEO since March 2007. TREAT ASIA UPDATE “amfAR’s 25 years of experience fighting AIDS 4 obligates us to do all we can in our efforts to end this pandemic,” Frost said upon his appointment. “And Fine-Tuning HAART for while the needs are great, amfAR is well positioned Treatment-Experienced to continue to make major contributions to HIV Pa5tients research, prevention, treatment, and advocacy in the coming years.” working together with civil society to build capacity RESEARCH Frost has worked extensively in Asia, where for scaling up treatment efforts in the region. HIV and the Brain he facilitated the development of amfAR’s TREAT Frost served as a member of the international amfAR to Be Honored Asia initiative, a network of more than 50 hospitals, advisory committee for the 2004 International AIDS With Adv6ocacy Award community clinics, NGOs, and healthcare facilities, Conference in Barcelona and was a member of the Rejuvenating the Field (continued on page 2) of AIDS Research 7 Global MSM Initiative Launched BENEFIT NEWS amfAR Program Addresses Shortage of HIV Services for Men Who Have Sex With Men 8 round the world, HIV remains a crisis among October and the Initiative’s initial round of grants A men who have sex with men (MSM), particu - is expected to be issued in January 2008, barely a Calendar larly in resource-limited settings. Globally, year from when the project was first conceived. less than one in 20 MSM has access to needed HIV “Through the MSM Initiative, we hope to 12 prevention, treatment, and care services, according foster collaboration among organizations, promote to UNAIDS. advocacy that transforms attitudes and discriminatory In an effort to meet this urgent need and to policies, and increase HIV/AIDS funding for MSM reduce rates of HIV infection among MSM in worldwide,” said amfAR CEO Kevin Frost, who developing countries, in July amfAR announced spearheaded the new project. an international MSM Initiative. After initiating With small, targeted grants aimed at grassroots discussions in early 2007, amfAR has moved speedily groups in resource-limited countries, the MSM to raise more than $1 million to support the Initiative. Initiative is expected to have an immediate and amfAR meets the BBB Wise The first request for proposals (RFP) was released in significant impact on communities with limited Giving Alliance Standards for Charity Accountability (continued on page 7) Winter 08:Fall 11/28/07 4:19 PM Page 2 amfAR Board of Trustees Kenneth Cole Chairman of the Board Patricia J. Matson Vice Chairman John C. Simons Sharon Stone Named Global Vice Chairman Wallace Sheft, C.P.A. Treasurer William D. Zabel, Esq. Fundraising Chairman Secretary Dame Elizabeth Taylor Founding International Chairman ong-time AIDS advocate and amfAR supporter Mathilde Krim, Ph.D. Founding Chairman Sharon Stone has been named amfAR’s global Arlen H. Andelson L fundraising chairman. Harry Belafonte David Bohnett Since becoming chairman of amfAR’s Campaign Zev Braun Jonathan S. Canno for AIDS Research in 1995, Stone has worked tirelessly Donald Capoccia Jane B. Eisner to heighten awareness of HIV/AIDS and to underscore Arnold W. Klein, M.D. Michael J. Klingensmith the urgent need for continued AIDS research. Her dynamic Michele V. McNeill, Pharm.D. Richard H. Metzner presence has been an indispensable element in a number Edward L. Milstein of highly successful amfAR benefits. Through personal Natasha Richardson Vincent A. Roberti appearances, benefit premieres of her movies, and other Allan Rosenfield, M.D. Alan D. Schwartz special events, she has helped amfAR raise millions of Diana L. Taylor Kevin Wendle dollars and has greatly increased AIDS awareness worldwide. Adjunct Trustees Stone’s new role was announced by Kenneth Cole, chairman of amfAR’s board of trustees, David E. Bloom, Ph.D. R. Martin Chavez, Ph.D. at the September 27 board meeting, the first attended by recently elected board members Natasha Mervyn F. Silverman, M.D., M.P.H. Mario Stevenson, Ph.D. Richardson and Diana L. Taylor. Richardson, an award-winning stage and screen actress, has Program Board conceived, organized, and spearheaded a number of highly successful amfAR events. She Allan Rosenfield, M.D. Chair received amfAR’s Award of Courage in November 2000. Taylor is a managing director of the investment banking firm of Wolfensohn & Co. She Dawn Averitt-Bridge David E. Bloom, Ph.D. also chairs a commission for the Federal Deposit Insurance Corporation that concentrates on Tim Brown, Ph.D. Alex Carballo-Dieguez, Ph.D. financially underserved communities, and is a member of the Council on Foreign Relations. I Willard Cates, Jr., M.D., M.P.H. R. Alta Charo, J.D. Grant N. Colfax, M.D. Hoosen Coovadia, M.D. Sherry Deren, Ph.D. Carl Dieffenbach, Ph.D. Wafaa El-Sadr, M.D., M.P.H. Sherry Glied, Ph.D. Leadership (continued from page 1) Margaret A. Hamburg, M.D. Adeeba Kamarulzaman, MBBS, FRACP Jennifer Kates, M.A., M.P.A. scientific committee for the 2006 International government health expert and spokesperson Mathilde Krim, Ph.D. Patrick C.K. Li, MBBS AIDS Conference in Toronto. He has also served for more than 20 years. She served as assistant Kenneth H. Mayer, M.D. William E. Paul, M.D. on the advisory panels for three U.S. Food and U.S. surgeon general; the first-ever deputy Mervyn F. Silverman, M.D., M.P.H. Peter Staley Drug Administration hearings on AIDS-related assistant secretary for women’s health; senior Mario Stevenson, Ph.D. David Vlahov, Ph.D. drug treatments. He has published in numerous global and e-health advisor in the U.S. In Memoriam journals including The Lancet, Journal of Clinical Department of Health and Human Services; Sheldon W. Andelson, Esq. Mrs. Albert D. Lasker Epidemiology, Journal of AIDS (JAIDS), Journal chief of the Behavioral Medicine and Basic Jonathan M. Mann, M.D., M.P.H. Maxine Mesinger of Infectious Diseases , and The AIDS Reader . Prevention Research Branch at the National Peter Scott, Esq. Prior to joining amfAR in 1994, Frost Institute of Mental Health; and as a White Tom Stoddard spent four years at New York University Medical House advisor on health issues. Sharon Stone Global Fundraising Chairman Center where he worked primarily on clinical Dr. Blumenthal is currently distinguished Management Group research studies of cytomegalovirus retinitis in advisor on health and medicine at the Center Kevin Robert Frost Chief Executive Officer people with HIV/AIDS. He also served for a for the Study of the Presidency and a clinical Susan J. Blumenthal, M.D., M.P.A. year as the inpatient care coordinator of the professor at Georgetown and Tufts Schools of Senior Medical and Policy Advisor Deborah C. Hernan AIDS program at New York City’s Bellevue Medicine. She is the recipient of numerous Vice President, Public Information Rowena Johnston, Ph.D. Hospital. awards, medals, and honorary doctorates for Vice President, Research Jeffrey Laurence, M.D. In addition to Frost’s appointment, Rear her landmark contributions to improving health. Senior Scientific Consultant Admiral Susan J. Blumenthal, M.D., M.P.A. Her work in the government has included a John F. Logan, Esq. Vice President and General Counsel (ret.), has been named senior medical and policy focus on HIV/AIDS since the beginning of Bill Melamed Vice President, Development advisor. Dr. Blumenthal has been a leading U.S. the epidemic in the early 1980s. I Scott Newman, M.B.A. Vice President, Finance and Administration Monica S. Ruiz, Ph.D., M.P.H. Acting Director, Public Policy The Newsletter of amfAR, The Foundation for AIDS Research • Winter 2008 Winter 08:Fall 11/28/07 4:19 PM Page 3 policy report Whither World Health? amfAR Co-Sponsors Global Health Symposium ome 400 experts from the fields S of science, public health, and poli - cy gathered to assess the current “With future pandemics, if we do far state of global health and to discuss a road too little, far too late, we will pay a map for future collaborative action at an amfAR-co-sponsored symposium at the huge price. That is what we’ve done Italian Embassy in Washington, D.C., with HIV .” October 11–12. The symposium featured presenta - tions by eminent figures such as Sir Richard Feachem, recently retired director of the Global Fund to Fight across national borders, amfAR’s senior care delivery, amfAR CEO Kevin Frost AIDS, Tuberculosis, and Malaria; Dr. medical and policy advisor Dr. Susan J. provided an overview of amfAR’s TREAT Anthony Fauci, director of the National Blumenthal, one of the meeting’s organiz - Asia initiative. Institute of Allergy and Infectious ers, noted, “Today, one nation’s problem New models for international aid, Diseases; and John Podesta, President is every nation’s problem. But the good such as TREAT Asia and the Global Bill Clinton’s chief of staff and now news is that solutions cross borders, too.” Fund, must be developed in order to president and CEO of the Center for Underestimating the mutability and effectively improve global health in the American Progress. Although discussions efficiency of the microbes that cause 21st century, stated Dr. Feachem. “In touched on a broad range of issues, time AIDS, tuberculosis, influenza, and other my 30 to 40 years I’ve seen huge progress and again speakers returned to two core deadly diseases is one the most dangerous and I’ve seen setbacks,” he concluded.